China Home Infusion Therapy Devices Market Size, Share, Trends and Forecasts 2031

Key Findings

• The China Home Infusion Therapy Devices Market is expanding rapidly due to the growing preference for home-based healthcare and rising incidence of chronic diseases requiring long-term intravenous (IV) treatments.

• Increasing adoption of portable infusion pumps and smart connected devices is transforming the home care delivery model across China.

• The aging population, coupled with the growing prevalence of diabetes, cancer, and infections, is fueling demand for continuous and flexible infusion solutions.

• Advancements in infusion pump design, catheter safety, and drug delivery accuracy are improving patient outcomes and safety.

• The integration of IoT-enabled monitoring systems and cloud-based platforms is enhancing remote therapy supervision and compliance.

• Healthcare cost-containment strategies and reimbursement policies supporting home care are accelerating market penetration in China.

• Rising awareness among patients about convenience, reduced hospital visits, and comfort associated with home infusion therapy is driving adoption.

• Collaborations between medical device manufacturers, healthcare providers, and telemedicine platforms are strengthening the home healthcare ecosystem.

China Home Infusion Therapy Devices Market Size and Forecast

The China Home Infusion Therapy Devices Market is projected to grow from USD 3.6 billion in 2025 to USD 7.2 billion by 2031, at a CAGR of 12.1% during the forecast period. Growth is primarily driven by the increasing shift from hospital-based to home-based care, technological innovation in infusion pumps, and rising healthcare expenditure in chronic disease management. In China, favorable reimbursement frameworks, hospital-at-home initiatives, and improved healthcare infrastructure are promoting the use of infusion devices in residential settings. Portable ambulatory pumps, needleless connectors, and advanced infusion catheters are making treatments safer and more efficient. Furthermore, digital integration through wireless monitoring and AI-assisted adherence tracking is reshaping the patient experience. As healthcare delivery models evolve toward remote monitoring and home-based management, the home infusion therapy devices market in China will continue to expand strongly through 2031.

Introduction

Home infusion therapy involves the administration of medications intravenously in the comfort of a patient’s home under medical supervision. It includes therapies such as antibiotics, chemotherapy, pain management, parenteral nutrition, and hydration. Infusion therapy devices, including pumps, catheters, and administration sets, are essential components enabling safe and accurate medication delivery. In China, the rising prevalence of chronic and post-surgical conditions requiring long-term infusion care has driven the rapid expansion of the home healthcare sector. The advancement of compact, battery-operated, and smart infusion pumps has facilitated easy patient use and remote supervision. Moreover, cost reduction compared to hospital stays and increased patient comfort are accelerating the adoption of home infusion therapies. The convergence of healthcare technology, telemedicine, and patient-centric care models is redefining the role of infusion devices in chronic disease management.

Future Outlook

By 2031, the China Home Infusion Therapy Devices Market will evolve toward personalized, connected, and fully automated infusion systems. Artificial intelligence (AI) will enable predictive dosing algorithms and early detection of complications, while Internet of Medical Things (IoMT) platforms will integrate real-time therapy data with clinician dashboards. Device miniaturization and wearable infusion systems will allow greater mobility and independence for patients. Robotics-assisted drug compounding and closed-loop infusion systems will enhance precision and reduce human errors. Homecare providers will increasingly use cloud-based therapy management software for patient monitoring, adherence tracking, and automated refill reminders. As healthcare systems prioritize outpatient care and cost efficiency, China is expected to emerge as a leading regional hub for digital infusion technologies and patient-centered home healthcare solutions.

China Home Infusion Therapy Devices Market Trends

• Shift Toward Home-Based and Ambulatory Care
  The rising demand for home healthcare and early hospital discharge programs is a key trend in China. Patients prefer receiving infusion therapies at home to minimize hospital-acquired infections and improve quality of life. Ambulatory and wearable infusion pumps are making home therapy more accessible, particularly for chronic patients. Healthcare systems are promoting decentralized care models to reduce the burden on hospitals and optimize resources.

• Technological Advancements in Infusion Pump Design
  Continuous innovation in infusion pump technology is improving therapy accuracy, safety, and user-friendliness. Smart pumps equipped with programmable features and dose error reduction systems (DERS) are gaining adoption in China. Portable infusion systems with integrated sensors ensure precise drug administration and real-time monitoring. These technological advancements are reducing adverse events and increasing patient confidence in home-based care.

• Integration of IoT and Remote Monitoring Solutions
  IoT-enabled infusion devices are transforming the management of home infusion therapy in China. Connected platforms allow healthcare professionals to remotely monitor infusion parameters, battery status, and patient adherence. Cloud-based solutions store patient data and provide alerts for flow rate deviations or catheter blockages. This real-time connectivity enhances safety, clinical efficiency, and care coordination between patients and providers.

• Rising Use of Infusion Therapy in Chronic Disease Management
  The growing prevalence of chronic conditions such as cancer, diabetes, and infections is driving the need for continuous or intermittent infusion therapy. In China, patients requiring long-term administration of insulin, antibiotics, or chemotherapeutic agents are increasingly opting for home infusion devices. These systems reduce hospitalization time, lower healthcare costs, and enhance patient satisfaction through personalized treatment delivery.

• Increased Focus on Patient Safety and Ease of Use
  Manufacturers are prioritizing ergonomic designs, safety features, and intuitive interfaces in infusion devices. Needleless connectors, air-in-line detectors, and occlusion sensors enhance safety during use. Simplified programming and touch-screen controls are enabling patients and caregivers to manage therapies independently. The trend toward user-friendly and intelligent infusion devices is central to the market’s continued growth in China.

Market Growth Drivers

• Rising Geriatric Population and Chronic Disease Burden
  The growing elderly population in China, combined with increasing incidences of cardiovascular, oncological, and metabolic disorders, is driving demand for home infusion therapy. Elderly patients prefer receiving continuous care in familiar environments, reducing the stress and cost associated with hospital visits. This demographic trend is expected to be a key driver of market growth.

• Healthcare Cost Containment and Policy Support
  Governments and healthcare payers in China are emphasizing cost-effective care models. Home infusion therapy significantly reduces hospital stay expenses, readmission rates, and infection risks. Reimbursement reforms and supportive insurance policies are further incentivizing the adoption of home-based infusion devices. Public health agencies are integrating homecare into chronic disease management frameworks.

• Technological Innovation and Device Connectivity
  Advancements in infusion device miniaturization, sensor integration, and wireless data transmission are transforming the home therapy landscape. Smart infusion systems with dose-tracking capabilities and AI-based analytics enhance precision and reduce adverse events. In China, connected devices are enabling better patient engagement and improving therapy adherence through digital monitoring.

• Expansion of Home Healthcare Services and Providers
  The rapid expansion of home healthcare companies and specialized infusion service providers is strengthening the market in China. Partnerships between device manufacturers and homecare agencies are improving device accessibility and service delivery. Mobile nursing support and training programs are ensuring safe therapy administration at home.

• Increasing Awareness of Infection Prevention and Patient Comfort
  The COVID-19 pandemic has accelerated awareness of infection prevention and home-based treatment benefits. Patients are seeking alternatives to inpatient care to minimize exposure risks. Home infusion devices offer both safety and convenience, making them essential for post-hospitalization recovery and long-term chronic therapy.

Challenges in the Market

• High Initial Equipment Costs and Maintenance Requirements
  The initial investment in infusion pumps and accessories can be significant, especially for advanced or connected devices. In China, high costs may limit adoption among low-income patients or small-scale homecare providers. Maintenance and calibration needs also add to overall operational expenses.

• Risk of Device-Related Complications
  Home infusion therapy carries potential risks such as catheter infections, air embolism, or dosage errors. In China, improper handling by untrained caregivers can lead to complications. Continuous patient education, monitoring systems, and training programs are critical to mitigating these risks.

• Lack of Skilled Healthcare Professionals for Homecare Support
  Shortages of trained homecare nurses and technicians can impede safe therapy administration. In remote areas of China, limited access to professional supervision restricts adoption. Strengthening workforce training and tele-nursing networks is necessary to ensure patient safety and care continuity.

• Regulatory Compliance and Quality Control Issues
  Compliance with medical device safety and data security regulations poses a challenge for manufacturers. Variations in regional approval processes and cybersecurity risks in connected devices can delay product launches. Establishing uniform regulatory frameworks and ensuring cybersecurity compliance are essential for market confidence.

• Connectivity and Infrastructure Barriers in Rural Areas
  While IoT and cloud-based devices are gaining traction in urban centers, limited internet connectivity in rural regions of China hampers adoption. Infrastructure gaps restrict remote monitoring and data synchronization. Addressing digital health inequities is key to maximizing the market’s potential.

China Home Infusion Therapy Devices Market Segmentation

By Product Type

• Infusion Pumps

  • Ambulatory Infusion Pumps

  • Syringe Infusion Pumps

  • Elastomeric Infusion Pumps

  • Volumetric Infusion Pumps

• Infusion Sets and Accessories

• Catheters

• Cannulas

• Needleless Connectors

By Application

• Anti-Infective Therapy

• Chemotherapy

• Parenteral Nutrition

• Hydration Therapy

• Pain Management

• Others

By Route of Administration

• Intravenous

• Subcutaneous

• Epidural

By End-User

• Homecare Settings

• Ambulatory Care Centers

• Specialty Clinics

• Hospitals (Transition Programs)

Leading Key Players

• Baxter International Inc.

• B. Braun Melsungen AG

• Fresenius Kabi AG

• ICU Medical, Inc.

• Smiths Medical (ICU Medical)

• Terumo Corporation

• Moog Inc.

• JMS Co., Ltd.

• Eitan Medical Ltd.

• KORU Medical Systems

Recent Developments

• Baxter International Inc. launched an advanced smart infusion pump in China featuring IoT connectivity and cloud-based remote monitoring.

• Fresenius Kabi AG expanded its home infusion solutions in China with new portable ambulatory pump systems designed for chronic disease management.

• B. Braun Melsungen AG introduced AI-enabled dose monitoring systems in China for real-time infusion therapy optimization.

• ICU Medical, Inc. partnered with homecare providers in China to deploy integrated infusion management platforms for patient tracking and safety alerts.

• Terumo Corporation unveiled a next-generation elastomeric infusion pump in China offering enhanced portability and automatic flow regulation for home patients.

This Market Report Will Answer the Following Questions

1. What is the projected market size and growth rate of the China Home Infusion Therapy Devices Market by 2031?

2. Which device categories and infusion technologies are driving market expansion in China?

3. How are IoT, AI, and remote monitoring reshaping home infusion therapy delivery?

4. What are the major challenges related to training, regulation, and connectivity in China?

5. Who are the leading companies driving innovation and home healthcare integration in the China Home Infusion Therapy Devices Market?